Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

Conditions:   Relapsed Pediatric ALL;   Relapsed Pediatric AML;   Refractory Acute Myeloid Leukemia;   Refractory Acute Lymphoblastic Leukemia Intervention:   Drug: Daunorubicin Sponsor:   Children's Mercy Hospital Kansas City Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials